SUBSCRIBE
SUBSCRIBE

ONL Therapeutics

IN THE PRESS
BioMidwest
ONL Therapeutics Receives Orphan Drug Designation For ONL1204 For Treatment Of Retinal Detachment From FDA
February 11, 2016
 · 
3 min read
BioMidwest
ONL Therapeutics To Present At The 2015 Ophthalmology Innovation Summit At American Academy of Ophthalmology Annual Meeting
October 30, 2015
 · 
3 min read
Business
ONL Therapeutics Announces Formation Of Scientific Advisory Board
October 15, 2015
 · 
6 min read
BioMidwest
ONL Therapeutics Provides Update On Novel Photoreceptor Protection Platform For Retinal Diseases
June 16, 2015
 · 
3 min read
BioMidwest
ONL Therapeutics To Present At Upcoming Investor And Scientific Conferences
March 16, 2015
 · 
2 min read
Business
ONL Therapeutics Announces Management Team Additions
December 3, 2014
 · 
4 min read
BioMidwest
ONL Therapeutics Receives Phase II National Eye Institute Grant From National Eye Institute For Development Of Novel Retinal Disease Treatment
November 12, 2014
 · 
3 min read
Load More
JOBS